Skip to content

Effect of Peer Mentoring and Blood Pressure Self-monitoring on Hypertension Control.

Effectiveness of Peer Mentoring and Blood Pressure Self-monitoring for Blood Pressure Control in Vulnerable Population in Argentina. A Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03297229
Enrollment
442
Registered
2017-09-29
Start date
2017-04-04
Completion date
2018-03-01
Last updated
2023-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Peer mentoring, Self-monitoring, Behavioral economics, Hypertension

Brief summary

Cardiovascular diseases are increasing throughout the developing world and are the cause of almost 16.7 million deaths each year, of which 80% occur in low and middle-income countries. As more than three fourth of the global burden of cardiometabolic diseases are related to risk factors connected with lifestyles or behaviors, such as smoking, unhealthy eating, low physical activity, and harmful consumption of alcohol. This burden could be dramatically reduced by changing individual behaviors. This study is focused on interventions that are aimed to improve the adherence to treatment in cardiovascular disease (hypertension), based on a Behavioral Economics approach. Most of public policies targeted to tackle Noncommunicable diseases utilize a rational economic model of behavior. Behavioral economics, by using insights from cognitive psychology and other social sciences, has drawn a lot of attention for its potential to increase healthy behaviors. Interventions informed by Behavioral economics principles seek to rearrange the social or physical environment in such a way to 'nudge' people towards healthier choices and behaviors. This is an individual controlled randomized trial which will be conducted to assess whether the implementation of two strategies, blood pressure self-monitoring plus signing a contract of commitment, and peer mentoring are effective to reduce blood pressure values over a period of 3 months, compared to usual care. This randomized trial will enroll 430 patients from 10 public primary care clinics in Argentina.

Interventions

BEHAVIORALPeer mentoring

Peers will be assigned to participants according to common socio-demographic characteristics. Each peer will be assigned up to 5 participants.

BEHAVIORALSelf-monitoring

Along with providing patients with a BP monitor, a commitment contract will be signed, in which participants commit themselves to measure their blood pressure at home at least once a week during the 3 months of the intervention. Each participant will be given a form to weekly recording their blood pressure values.

Sponsors

Inter-American Development Bank
CollaboratorOTHER
Institute for Clinical Effectiveness and Health Policy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (21 years and older) who only have public health coverage, and have high blood pressure (SBP ≥140 mmHg and / or DBP ≥90 mmHg)

Exclusion criteria

* Pregnant women, bed-bound, and patients who cannot give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure3 monthsNet change in blood pressure levels from baseline to the end of follow-up in in each group.

Secondary

MeasureTime frameDescription
Controlled hypertension3 monthsProportion of patients with controlled hypertension (Systolic blood pressure \<140 mm Hg and diastolic blood pressure \<90 mm Hg)
Adherence to antihypertensive medication3 monthsProportion of patients who had adhered to antihypertensive medication according to the Morisky Green Scale.
Intensification of antihypertensive medication3 monthsProportion of patients who increased the number of antihypertensive medications or increase the dose of their antihypertensive medication.
Visits to the clinic3 monthsNumber of visits to the clinic over the 3 month period of follow-up.

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026